Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine practice.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0168-8227(93)90145-UPMID 8472620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Care of Diabetic Patients by Optometrists in New York State

  1991cited by this paper
• Devices for insulin administration.

  1990cited by this paper
• Devices for Insulin Administration

  1990cited by this paper
• Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self‐selecting insulin‐dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences

  1990cited by this paper
• Prevalence of obesity in Sweden: cross‐sectional study of a representative adult population

  1990cited by this paper
• Prevalence of anti-insulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patients.

  1990cited by this paper
• The prevalence of impaired glucose counter-regulation during an insulin-infusion test in insulin-treated diabetic patients prone to severe hypoglycaemia

  1989cited by this paper
• Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for Type 1 (insulin-dependent) diabetes mellitus: a one centre experience

  1989cited by this paper
• Factors Related to Discontinuation of Continuous Subcutaneous Insulin-Infusion Therapy

  1988cited by this paper
• Reduction of severe hypoglycemic events in type I (insulin dependent) diabetic patients using continuous subcutaneous insulin infusion.

  1988cited by this paper
• Near-normoglycemia and late diabetic complications. The Oslo Study.

  1987cited by this paper
• Evaluation of insulin pump treatment under routine conditions.

  1987cited by this paper
• Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group

  1987cited by this paper
• Surveillance in Florida of Continuous Subcutaneous Insulin Infusion Use in Cohort

  1986cited by this paper
• Altered Recognition of Hypoglycaemic Symptoms in Type I Diabetes during Intensified Control with Continuous Subcutaneous Insulin Infusion

  1986cited by this paper
• Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated.

  1986cited by this paper
• Hypoglycemia and Counterregulation in Insulin-Dependent Diabetic Patients: A Comparison of Continuous Subcutaneous Insulin Infusion and Conventional Insulin Injection Therapy

  1986cited by this paper
• Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.

  1985cited by this paper
• Long-term follow-up of diabetic patients using insulin infusion pumps. Considerations for future clinical application.

  1985cited by this paper
• Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients.

  1984cited by this paper
• Hypoglycemic episodes during continuous subcutaneous insulin infusion: decreased frequency but increased susceptibility.

  1984cited by this paper
• Diet and pump-treated diabetes: a long-term follow-up.

  1983cited by this paper
• The Importance of Intensive Supervision in Determining the Efficacy of Insulin Pump Therapy

  1983cited by this paper
• Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections.

  1982cited by this paper
• A nomograph method for assessing body weight.

  1976cited by this paper

• Characteristics of nursing studies in diabetes research published over three decades in Sweden, Norway, Denmark and Iceland: a narrative review of the literature.

  2016cites this paper
• Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

  2009cites this paper
• Patient management of long-term continuous subcutaneous insulin infusion.

  2005cites this paper
• Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

  2004cites this paper
• Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of Therapy

  2004cites this paper
• Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of Hypoglycemia

  2003cites this paper
• Insulin pump therapy in patients with Type 1 diabetes mellitus: results of the Nationwide Quality Circle in Germany (ASD) 1999-2000.

  2003cites this paper
• Continuous Subcutaneous Insulin Infusion in Patients with Diabetes Mellitus

  2003cites this paper
• Insulin pump therapy: a meta-analysis.

  2003cites this paper
• Insulin pump therapy: a meta-analysis: Response to Weissberg-Benchell et al. Authors' reply

  2003cites this paper
• Tratamento do diabetes mellitus tipo 1 com bomba de infusão subcutânea contínua de insulina e insulina lispro

  2001cites this paper
• Efficacy of insulin pump therapy: mealtime delivery is the key factor.

  2000cites this paper
• Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes

  1996cites this paper
• Insulin pump therapy: acceptable alternative to injection therapy.

  1996cites this paper
• Glucose control with two different basal insulin delivery regimens during CSII in patients with Type 1 diabetes

  1996cites this paper
• Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.

  1995cites this paper
• Long-term compliance of intensified insulin therapy.

  1994cites this paper
• Alteration of the Risk Factor Paradigm for Discontinuance of Insulin Pump Therapy

  1994cites this paper
• Response to Wredling et al.

  1994cites this paper